The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Synergistic antitumor activity of GLIX1, a small molecule TET2 activator, in combination with PARP inhibition across multiple cancers.
 
Adam Robertson
Employment - Hemispherian; Syneos Health (I)
Leadership - Hemispherian
Stock and Other Ownership Interests - Hemispherian
Research Funding - Hemispherian
 
Guro Kristoffersen
Employment - Hemispherian
Research Funding - Hemispherian
 
Sandra Cantilena
Employment - Hemispherian
Research Funding - Hemispherian
 
Zeno Albisser
Employment - Hemispherian
Leadership - Hemispherian
Stock and Other Ownership Interests - Hemispherian
Research Funding - Hemispherian
 
Ella Sorani
Employment - BiolineRx
Leadership - BiolineRx
Stock and Other Ownership Interests - BiolineRx
Honoraria - BiolineRx
Consulting or Advisory Role - Sapience Therapeutics
Research Funding - BiolineRx (Inst)
Patents, Royalties, Other Intellectual Property - Patents as per policy of Biolinerx, no Royalties (Inst)
Travel, Accommodations, Expenses - BiolineRx